Question · asked by 1 review

Prophylactic aciclovir (oral or intravenous) vs placebo: Presence/absence of HSV oral lesions

Population
Patients being treated for cancer (predominantly haematological malignancies)
Intervention
Prophylactic aciclovir (oral or intravenous)
Comparison
placebo
Outcome
Presence/absence of HSV oral lesions

Prophylactic aciclovir (oral or intravenous) led to lower presence/absence of HSV oral lesions compared with placebo; GRADE not reported.

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Prophylactic aciclovir (oral or intravenous) vs Placebo
Presence/absence of HSV oral lesions · Patients being treated for cancer (predominantly haematological malignancies)
Prophylactic aciclovir (oral or intravenous) led to lower presence/absence of HSV oral lesions compared with placebo; GRADE not reported.
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer (2009) · Cochrane All outcomes
RR 0.16 [0.08, 0.31]9 studies · 398 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer
2009 · Cochrane All outcomes
2008-11Not listedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.